Management of Acute Tubulointerstitial Nephritis

Area of Science:

• Nephrology
• Immunology
• Pathology

Background:

• Acute tubulointerstitial nephritis (ATIN) is a significant global cause of acute kidney injury (AKI) and acute kidney disease.
• It involves immune cell infiltration in the renal tubulointerstitium, leading to inflammation, tubular damage, and potential fibrosis.
• Common triggers include drug-induced hypersensitivity (over 70%), infections, and autoimmune conditions, with some cases being idiopathic.

Purpose of the Study:

• To highlight the diagnostic challenges of ATIN, including clinical and laboratory overlaps with other AKI causes.
• To emphasize the importance of early recognition and management of ATIN.
• To discuss current treatment strategies and prognosis for ATIN.

Main Methods:

• Review of existing literature on ATIN pathophysiology, diagnosis, and management.
• Emphasis on the diagnostic role of kidney biopsy as the gold standard.
• Discussion of clinical presentations, including oligosymptomatic AKI with minimal urinary findings.

Main Results:

• Drug-induced hypersensitivity is the predominant cause of ATIN.
• Diagnosis can be challenging due to overlapping symptoms with other AKI etiologies.
• Kidney biopsy remains crucial for definitive ATIN diagnosis.

Conclusions:

• Prompt identification and removal of the underlying trigger are essential for managing ATIN.
• While generally having a favorable prognosis with timely intervention, delayed diagnosis or continued exposure can lead to irreversible fibrosis and chronic kidney disease (CKD).
• Further research, including robust randomized controlled trials, is needed to guide immunosuppressive therapy for noninfectious ATIN.